DNA診断市場：製品タイプ、技術、サンプルタイプ、用途、エンドユーザー別-2025-2030年世界予測

DNA診断市場は、2023年に113億7,000万米ドルと評価され、2024年には124億米ドルに達すると予測され、CAGR 9.24％で成長し、2030年には211億2,000万米ドルに達すると予測されています。

DNA診断市場には、主に遺伝性疾患の検出、同定、法医学的応用を目的とした、遺伝物質の検査に使用される多様な技術が網羅されています。この分野は、出生前診断、感染症検出、先祖伝来の遺産探索から個別化医療や医薬品アプリケーションに至るまで、さまざまなアプリケーションを包含しているため、現代医療や法医学において不可欠です。個別化ヘルスケアの需要が高まるにつれて、その応用範囲は予測的で個別化された治療計画や標的薬剤開発へと拡大しています。この市場は、ヘルスケアプロバイダー、調査機関、法医学部門、消費者向け直接サービスなど、さまざまなエンドユーザーにサービスを提供しています。主な成長要因としては、遺伝子配列決定のコストが急速に低下していること、CRISPRや次世代配列決定などの技術的進歩、診断的介入が必要な遺伝性疾患の有病率が上昇していることなどが挙げられます。さらに、消費者の遺伝子検査に対する認識と受容が市場の成長を後押ししています。最近では、診断能力を強化するためのバイオテクノロジー企業とヘルスケアプロバイダーとの提携や、データ処理プロセスを合理化するためのAIの統合という形で、大きなビジネスチャンスが生まれています。しかし、厳しい規制の枠組み、遺伝子のプライバシーに関する倫理的懸念、遺伝子データの解釈の複雑さなどの課題が、成長の限界となっています。技術革新の最良の道は、DNA検査ツールの精度と価格の向上、データ解析のための高度なバイオインフォマティクス・ツールの開発、従来の用途を超えた遺伝子診断の有用性の拡大にあります。さらに、遺伝子データへの容易なアクセスと解釈を促進する消費者フレンドリーなプラットフォームを構築することで、市場の拡大がさらに促進される可能性があります。市場情勢は力強い成長を遂げようとしているが、その可能性を最大限に活用するためには、規制状況やデータセキュリティの課題を効果的に解決する必要があります。

市場力学：急速に進化するDNA診断市場の主要市場インサイトを公開

DNA診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 世界の遺伝性疾患の有病率の増加
  • 遺伝子検査とそれに関連する利益に対する意識の高まり
  • 個別化医療への傾向の高まり
• 市場抑制要因
  • DNA診断検査のコスト高
• 市場機会
  • DNA診断とデジタルヘルスプラットフォームやアプリとの統合
  • 非侵襲的DNA検査法の継続的進歩
• 市場の課題
  • 一部のDNA診断検査の精度と信頼性に関する懸念

ポーターの5つの力：DNA診断市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：DNA診断市場における外部からの影響の把握

外部マクロ環境要因は、DNA診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析DNA診断市場における競合情勢の把握

DNA診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスDNA診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、DNA診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨DNA診断市場における成功への道筋を描く

DNA診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患の世界の増加
    • 遺伝子検査とその利点についての認識の高まり
    • パーソナライズ医療へのトレンドの高まり
  • 抑制要因
    • DNA診断検査の高コスト
  • 機会
    • DNA診断とデジタルヘルスプラットフォームおよびアプリの統合
    • 非侵襲性DNA検査法の継続的な進歩
  • 課題
    • 一部のDNA診断検査の精度と信頼性に関する懸念
• 市場セグメンテーション分析
  • 製品タイプ：病院や診療所における広範な患者データ分析のためのソフトウェアやサービスに対する需要が高まっています。
  • エンドユーザー：病院や診療所におけるポイントオブケア検査ソリューションと迅速診断キットの需要の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 DNA診断市場：製品タイプ別

• 機器/ハードウェア
• 試薬・消耗品
• ソフトウェアとサービス

第7章 DNA診断市場：技術別

• CRISPR診断
• 蛍光in situハイブリダイゼーション
• マイクロアレイ技術
• 次世代シーケンシング
• ポリメラーゼ連鎖反応
• サンガーシーケンス

第8章 DNA診断市場サンプルタイプ別

• 血液サンプル
• 唾液サンプル
• 組織サンプル

第9章 DNA診断市場：用途別

• がん診断
• 法医学検査
• 遺伝性疾患検査
• ヒト白血球抗原タイピング
• 感染症検査
• 着床前遺伝子診断
• 出生前/新生児診断
• 移植診断

第10章 DNA診断市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 診断検査室
• 病院・クリニック
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのDNA診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のDNA診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのDNA診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バイオ・ラッドとオンコサイトが協力し、ドナー由来の無細胞DNAを正確に検出する最先端のddPCRアッセイで移植モニタリングに革命を起こす
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Adaptive Biotechnologies
• Agilent Technologies, Inc.
• ARUP Laboratories
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioMerieux
• Danaher Corporation
• DNA Diagnostic A/S
• Eurofins
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• Luminex Corporation
• Myriad Genetics
• Natera, Inc.
• Oxford Nanopore Technologies PLC
• Promega Corporation
• QIAGEN GmbH
• Quest Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Veracyte, Inc.

LIST OF FIGURES

• FIGURE 1. DNA DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. DNA DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DNA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. DNA DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. DNA DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DNA DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DNA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DNA DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/HARDWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CRISPR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRENATAL/NEONATAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. CANADA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. CHINA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. CHINA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. INDIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. INDIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. SOUTH KOREA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. TAIWAN DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. THAILAND DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. VIETNAM DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. DENMARK DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. EGYPT DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. FINLAND DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. FRANCE DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. GERMANY DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. ISRAEL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. ITALY DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. ITALY DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. ITALY DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. ITALY DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. ITALY DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NETHERLANDS DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. NIGERIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. NORWAY DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. POLAND DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. POLAND DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. POLAND DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. POLAND DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. POLAND DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. QATAR DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. QATAR DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. QATAR DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. QATAR DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. QATAR DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. RUSSIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SAUDI ARABIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH AFRICA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SPAIN DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. SWEDEN DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. SWITZERLAND DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. TURKEY DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. UNITED ARAB EMIRATES DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. UNITED KINGDOM DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 246. DNA DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 247. DNA DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The DNA Diagnostics Market was valued at USD 11.37 billion in 2023, expected to reach USD 12.40 billion in 2024, and is projected to grow at a CAGR of 9.24%, to USD 21.12 billion by 2030.

The DNA Diagnostics market encompasses a diverse array of techniques used to examine genetic material, aimed primarily at detecting genetic disorders, identification, and forensic applications. This field is indispensable in modern medicine and forensics, as it encompasses a range of applications from prenatal diagnostics, infectious disease detection, ancestral heritage exploration, to personalized medicine and pharmaceutical applications. With growing demand for personalized healthcare, the application scope is expanding into predictive and personalized treatment plans, as well as targeted drug development. This market serves varied end-users including healthcare providers, research institutes, and forensic departments, as well as direct-to-consumer services. Key growth factors include the rapidly declining costs of genetic sequencing, technological advancements such as CRISPR and next-generation sequencing, and a rising prevalence of genetic disorders necessitating diagnostic interventions. Moreover, awareness and acceptance of genetic testing among consumers are bolstering market growth. Recently, significant opportunities have emerged in the form of partnerships between biotech companies and healthcare providers to enhance diagnostic capabilities, as well as the integration of AI to streamline data handling processes. However, challenges such as stringent regulatory frameworks, ethical concerns regarding genetic privacy, and the complexity of genetic data interpretation pose limitations to growth. The best avenues for innovation lie in enhancing the accuracy and affordability of DNA testing tools, developing advanced bioinformatics tools for data analysis, and expanding the utility of genetic diagnostics beyond traditional applications. Additionally, creating consumer-friendly platforms to facilitate easy access and interpretation of genetic data could further stimulate market expansion. While the DNA Diagnostics market is poised for robust growth, businesses must navigate regulatory landscapes and data security challenges effectively to harness its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA Diagnostics Market

The DNA Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of genetic disorders globally
  • Growing awareness about genetic testing and its associated benefits
  • Rising trend towards personalized medicines
• Market Restraints
  • High cost of DNA diagnostic tests
• Market Opportunities
  • Integration of DNA diagnostics with digital health platforms and apps
  • Ongoing advancements in non-invasive DNA testing methods
• Market Challenges
  • Concerns associated with the accuracy and reliability of some DNA diagnostic tests

Porter's Five Forces: A Strategic Tool for Navigating the DNA Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA Diagnostics Market

A detailed market share analysis in the DNA Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA Diagnostics Market

A strategic analysis of the DNA Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies, Agilent Technologies, Inc., ARUP Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux, Danaher Corporation, DNA Diagnostic A/S, Eurofins, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Myriad Genetics, Natera, Inc., Oxford Nanopore Technologies PLC, Promega Corporation, QIAGEN GmbH, Quest Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., and Veracyte, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Instruments/Hardware, Reagents & Consumables, and Software & Services.
• Based on Technology, market is studied across CRISPR Diagnostics, Fluorescence In Situ Hybridization, Microarray Techniques, Next-Generation Sequencing, Polymerase Chain Reaction, and Sanger Sequencing.
• Based on Sample Type, market is studied across Blood Samples, Saliva Samples, and Tissue Samples.
• Based on Application, market is studied across Cancer Diagnostics, Forensic Testing, Genetic Disease Testing, Human Leukocyte Antigen Typing, Infectious Disease Testing, Preimplantation Genetic Diagnosis, Prenatal/Neonatal Diagnostics, and Transplant Diagnostics.
• Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, Diagnostic Laboratories, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of genetic disorders globally
    • 5.1.1.2. Growing awareness about genetic testing and its associated benefits
    • 5.1.1.3. Rising trend towards personalized medicines
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of DNA diagnostic tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of DNA diagnostics with digital health platforms and apps
    • 5.1.3.2. Ongoing advancements in non-invasive DNA testing methods
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the accuracy and reliability of some DNA diagnostic tests
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type : Increasing preference for software and services in hospitals and clinics for extensive patient data analysis
  • 5.2.2. End User : Rising demand for point-of-care testing solutions and rapid diagnostic kits in hospitals and clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA Diagnostics Market, by Product Type

• 6.1. Introduction
• 6.2. Instruments/Hardware
• 6.3. Reagents & Consumables
• 6.4. Software & Services

7. DNA Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. CRISPR Diagnostics
• 7.3. Fluorescence In Situ Hybridization
• 7.4. Microarray Techniques
• 7.5. Next-Generation Sequencing
• 7.6. Polymerase Chain Reaction
• 7.7. Sanger Sequencing

8. DNA Diagnostics Market, by Sample Type

• 8.1. Introduction
• 8.2. Blood Samples
• 8.3. Saliva Samples
• 8.4. Tissue Samples

9. DNA Diagnostics Market, by Application

• 9.1. Introduction
• 9.2. Cancer Diagnostics
• 9.3. Forensic Testing
• 9.4. Genetic Disease Testing
• 9.5. Human Leukocyte Antigen Typing
• 9.6. Infectious Disease Testing
• 9.7. Preimplantation Genetic Diagnosis
• 9.8. Prenatal/Neonatal Diagnostics
• 9.9. Transplant Diagnostics

10. DNA Diagnostics Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Diagnostic Laboratories
• 10.5. Hospitals & Clinics
• 10.6. Pharmaceutical & Biotechnology Companies

11. Americas DNA Diagnostics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific DNA Diagnostics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa DNA Diagnostics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Bio-Rad and OncoCyte Join Forces to Revolutionize Transplant Monitoring with Cutting-Edge ddPCR Assay for Accurate Donor-Derived Cell-Free DNA Detection
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Adaptive Biotechnologies
• 3. Agilent Technologies, Inc.
• 4. ARUP Laboratories
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. BioMerieux
• 8. Danaher Corporation
• 9. DNA Diagnostic A/S
• 10. Eurofins
• 11. Exact Sciences Corporation
• 12. F. Hoffmann-La Roche Ltd.
• 13. Hologic, Inc.
• 14. Illumina, Inc.
• 15. Invitae Corporation
• 16. Laboratory Corporation of America Holdings
• 17. Luminex Corporation
• 18. Myriad Genetics
• 19. Natera, Inc.
• 20. Oxford Nanopore Technologies PLC
• 21. Promega Corporation
• 22. QIAGEN GmbH
• 23. Quest Diagnostics
• 24. Siemens Healthineers
• 25. Sysmex Corporation
• 26. Thermo Fisher Scientific Inc.
• 27. Veracyte, Inc.